Two new canine medications were approved by the United States Food and Drug Administration (FDA) in June 2015.
Coraxis™
Coraxis is produced by Bayer HealthCare LLC, Animal Health Division and was approved on June 6th. According to the FDA this medication is used “For the prevention of heartworm disease caused by Dirofilaria immitis, and for the treatment and control of Ancylostoma caninum (adults, immature adults, and fourth stage larvae), Uncinaria stenocephala (adults, immature adults, and fourth stage larvae), Toxocara canis (adults and fourth stage larvae), Toxascaris leonina (adults), and Trichuris vulpis (adults) in dogs and puppies that are at least 7 weeks of age and that weigh at least 3 pounds.”
Cerenia is produced by Zoetis Inc. and was approved on June 17th. According to the FDA, “This supplement provides for extension of the number of days of consecutive use from “5 days” to “until resolution of acute vomiting” for the prevention of acute vomiting in dogs 7 months and older.”
